"We await results of a mouse immunogenicity study
Post# of 36537
(Total Views: 247)
Posted On: 02/03/2021 10:36:45 AM
"We await results of a mouse immunogenicity study requested
by FDA to demonstrate the ability of the Ii-Key-SARS-CoV-2 vaccine to elicit a
neutralizing antibody response and the T cell activation to generate a long-term
memory immune response, thereby demonstrating the potential for a Complete
Vaccine™ against COVID-19. We are using this transgenic mouse model that is
genetically modified with part of the human immune system called the Human
Leukocyte Antigen (HLA) to study T cell activation in an animal model of the human
immune system."
This is not tox study which can take 6 months. The FDA told them they didn't need to do that based on tech being safe.
by FDA to demonstrate the ability of the Ii-Key-SARS-CoV-2 vaccine to elicit a
neutralizing antibody response and the T cell activation to generate a long-term
memory immune response, thereby demonstrating the potential for a Complete
Vaccine™ against COVID-19. We are using this transgenic mouse model that is
genetically modified with part of the human immune system called the Human
Leukocyte Antigen (HLA) to study T cell activation in an animal model of the human
immune system."
This is not tox study which can take 6 months. The FDA told them they didn't need to do that based on tech being safe.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼